<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">7801727</journal-id><journal-id journal-id-type="pubmed-jr-id">3636</journal-id><journal-id journal-id-type="nlm-ta">Eval Program Plann</journal-id><journal-id journal-id-type="iso-abbrev">Eval Program Plann</journal-id><journal-title-group><journal-title>Evaluation and program planning</journal-title></journal-title-group><issn pub-type="ppub">0149-7189</issn><issn pub-type="epub">1873-7870</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40435551</article-id><article-id pub-id-type="pmc">12439252</article-id><article-id pub-id-type="doi">10.1016/j.evalprogplan.2025.102610</article-id><article-id pub-id-type="manuscript">NIHMS2085686</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Advancing Methods for Program Evaluation in Substance Use by Strengthening the Application of Epidemiology, Economic Evaluation, and Implementation Science: Reflections on the Opportunities for Synergy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Blackburn</surname><given-names>Natalie A.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Philbrick</surname><given-names>Sarah</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Patel</surname><given-names>Sheila V.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Cance</surname><given-names>Jessica D.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Elek</surname><given-names>Elvira</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Gibbons</surname><given-names>Brent</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Sazid</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Lambdin</surname><given-names>Barrot H.</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Graham</surname><given-names>Phillip W.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>RTI International, Research Triangle Park, NC, United States</aff><aff id="A2"><label>2</label>NOVA National School of Public Health, Comprehensive Health Research Centre, NOVA University Lisbon, Lisbon, Portugal</aff><aff id="A3"><label>3</label>RTI International, 701 13th Street NW, Suite 750, Washington, DC, United States</aff><aff id="A4"><label>4</label>RTI International, 2150 Shattuck Avenue, 8th Floor, Berkeley, CA, United States</aff><author-notes><fn fn-type="other" id="FN1"><p id="P1">Author Statement</p><p id="P2">Natalie A. Blackburn: conceptualization, methodology, writing &#x02013; original draft. Sarah Philbrick: methodology, writing &#x02013; original draft. Sheila V. Patel: conceptualization, methodology, writing &#x02013; reviewing and editing. Jessica D. Cance: conceptualization, methodology, writing &#x02013; reviewing and editing. Elvira Elek: methodology, writing &#x02013; reviewing and editing. Brent Gibbons: writing &#x02013; reviewing and editing. Sazid Khan: writing &#x02013; reviewing and editing. Barrot Lambdin: conceptualization, funding acquisition, writing &#x02013; reviewing and editing. Phillip Graham: conceptualization, funding acquisition, writing &#x02013; reviewing and editing.</p></fn><fn fn-type="con" id="FN3"><p id="P3">Authors&#x02019; Contributions</p><p id="P4">NAB facilitated the development, drafting, editing, and corrections of the manuscript. SP contributed with a critical review; helped draft the sections; and contributed with additions, literature citations, and edits in different subsections of the manuscript. SVP contributed with a critical review, literature citations, and edits in different subsections of the manuscript. JDC contributed with edits in different subsections of the manuscript. EE contributed with edits in different subsections of the manuscript. BG contributed with literature citations and edits in different subsections of the manuscript. SK contributed with literature citations and edits in different subsections of the manuscript. BHL provided early support for the main conceptual ideas and contributed with input for different subsections of the manuscript. PG conceived the main conceptual ideas and contributed with edits in different subsections of the manuscript. All authors contributed to the article and approved the submitted version.</p></fn><corresp id="CR1"><label>*</label><bold>Correspondence:</bold> Natalie A. Blackburn, Campo M&#x000e1;rtires da P&#x000e1;tria 130, Lisbon, 1169-056, Portugal, <email>natblackburn@gmail.com</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>30</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>19</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>8</month><year>2026</year></pub-date><volume>111</volume><fpage>102610</fpage><lpage>102610</lpage><abstract id="ABS1"><p id="P5">Program evaluation is necessary to assess the success of evidence-based programs in real-world, non-trial settings. In its most basic form, it involves understanding processes that impact the health and well-being of individuals and communities. Increasingly, robust program evaluations are integrating approaches from implementation science and economic evaluation to strengthen assessment, achievement, and sustainment of the intended impacts of evidence-based programs, while traditionally employing epidemiological methods to assess outcomes. Epidemiology, economic evaluation, and implementation science operate in overlapping yet siloed arenas, which can make it challenging for program evaluators to effectively engage all three disciplines. Furthermore, given their overlap, practitioners in these disciplines must understand differences in their purpose and lexicon to foster synergies. We use the Centers for Disease Control and Prevention Evaluation Framework and an example from substance use prevention to reflect on specific concepts and terminology within each of these disciplines and how distinctions impact the ability of multidisciplinary teams to collaborate on evaluations. The implications apply to those designing, testing, implementing, and evaluating evidence-based programs&#x02014;all of whom have the opportunity to consider and strengthen these elements when developing processes and measuring impact. The substance use prevention field needs to better understand how these disciplines can complement one another to enrich process, outcome, and impact evaluations, given the complexities of substance use behaviors and evidence-based programs to address them. With this synergy, clearer communication of findings from the different components can be achieved.</p></abstract><kwd-group><kwd>economic evaluation</kwd><kwd>epidemiology</kwd><kwd>implementation science</kwd><kwd>program evaluation</kwd><kwd>substance use prevention</kwd></kwd-group></article-meta></front><body><sec id="S1"><label>1</label><title>Background</title><p id="P6">Once programs are determined to be evidence based through rigorous research, they need to be disseminated and implemented in practice thoughtfully to ensure anticipated outcomes are achieved in the &#x0201c;real world.&#x0201d; Program evaluation is an approach that allows for assessing programs in the real world, enabling the monitoring of delivery to identify when a program fails to achieve anticipated outcomes, and what is not working for whom and how, to prompt changes to facilitate outcome achievement (<xref rid="R1" ref-type="bibr">1</xref>). Although some may understand the purpose and language of individual disciplines (e.g., epidemiology, economic evaluation, implementation science) for program evaluation, a gap remains in understanding how these individual disciplines can complement one another in the service of program evaluation. Part of this gap stems from discipline-specific lexicons that make communicating commonalities challenging.</p><p id="P7">In its most basic form, program evaluation provides a systematic method for collecting, analyzing, and communicating answers to questions, particularly about effectiveness, efficiencies in delivery, and resource use (<xref rid="R2" ref-type="bibr">2</xref>). Rooted in a rich history of education programs and social sciences, program evaluation is interdisciplinary in its nature and approach. To varying degrees across different areas, program evaluations traditionally incorporate the strengths of multiple disciplines including psychology, anthropology, and sociology in order to assess the worth and impact of a program. Public health program evaluation was further strengthened with the development of the CDC Framework for Program Evaluation in Public Health (<xref rid="R1" ref-type="bibr">1</xref>). Many evaluation approaches exist to guide program evaluations; indeed, like application of the CDC Evaluation Framework, these approaches are used to document the strengths and weaknesses of programs and, when appropriate, make recommendations for program improvements.</p><p id="P8">The substance use prevention landscape has placed increasing importance on the value (<xref rid="R3" ref-type="bibr">3</xref>) and sustainability of programs while still remaining steadfast about program impact. Applied epidemiology, as a key discipline informing program evaluation, is pivotal for assessing impact and has provided a set of approaches for defining outcomes of interest and measuring effectiveness as part of the development, testing, and evaluation of evidence-based programs to prevent substance misuse. A program evaluator may use epidemiological measures, such as incidence and prevalence of prescription opioid misuse among high school seniors, to assess the impact of a substance misuse prevention education program. Alongside impact, the focus on value and sustainability requires stronger incorporation of economic evaluation and implementation science, along with greater clarity in the application of these fields within program evaluation. For example, implementation research defines and tests strategies to overcome challenges and leverage strengths to successfully integrate, deliver, scale, and sustain a program. Economic evaluations provide information on the comparative value of programs, information needed by policymakers and potential adopters when making decisions about which programs are the best use of limited budget resources. Additionally, economic evaluations can help program adopters and deliverers to understand what costs to expect when starting up and delivering a program. Therefore, planning for and collecting cost data often plays a critical role in program evaluations. Although collecting implementation-related and cost data is not new in program evaluation, collection often gets integrated late in the evaluation process. Integrating more refined implementation and economic evaluation methods at the outset of substance use prevention program evaluations will produce more precise information to better inform decision makers and potential adopters.</p><p id="P9">Implementation scientists and health economists have each sought to clarify and define key terminology in their own fields (<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R6" ref-type="bibr">6</xref>). As research integrating these two fields has grown, with some even conducting economic evaluation of implementation strategies, efforts to ensure common language across disciplines have fallen short (<xref rid="R7" ref-type="bibr">7</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref>). In addition to a discordant lexicon, timelines in data collection and when the fields are relevant in the evaluation process differ such that opportunities to communicate and engage with one another when conducting program evaluations are missed. Program evaluation, with its interdisciplinary nature, requires communicating across different discipline lexicons. The lack of opportunities to engage with one another makes efforts to define common language even more challenging. Thus, there is a need to engage these disciplines early in the evaluation process, crosswalk key concepts, and harmonize language across these disciplines. Doing so avoids duplication of efforts and supports real-world delivery and evaluation of evidence-based programs.</p></sec><sec id="S2"><label>2</label><title>Aims and Objectives</title><p id="P10">This paper seeks to bring together different methodological perspectives in designing and conducting program evaluation in substance use prevention in three specific disciplines: epidemiology, economic evaluation, and implementation science. These disciplines can strengthen the design and delivery of program evaluations and inform policy and practice. We focus on three key areas: language within each discipline, application of each discipline in evaluation, and the opportunities for synergy across disciplines. Specifically, we aim to provide tangible approaches to integrating these disciplines within existing program evaluation frameworks. We first describe each discipline&#x02019;s lexicon and how similar terms are applied, then use the Centers for Disease Control and Prevention (CDC) Evaluation Framework (<xref rid="R10" ref-type="bibr">10</xref>&#x02013;<xref rid="R12" ref-type="bibr">12</xref>) as an example for incorporating disciplines into program evaluation, showcasing opportunities for application, and strengthening existing evaluation approaches.</p></sec><sec id="S3"><label>3</label><title>Discussion</title><sec id="S4"><label>3.1</label><title>Discipline Summaries</title><p id="P11">Summaries of the disciplines, including definitions, key elements, and example publication reporting standards, are presented in <xref rid="T1" ref-type="table">Table 1</xref> and described as follows.</p><sec id="S5"><label>3.1.1</label><title>Epidemiology</title><p id="P12">Briefly, epidemiology developed as a discipline to consider disease across populations rather than individuals (<xref rid="R13" ref-type="bibr">13</xref>). The definition of epidemiology has evolved and continues to differ among epidemiologists (<xref rid="R14" ref-type="bibr">14</xref>). Furthermore, current definitions vary across institutions; CDC defines epidemiology as &#x0201c;the study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems.&#x0201d; Program evaluators can find that epidemiological practices, methods, and techniques can be of use in many areas. For example, epidemiological data provide the foundation for understanding the health status, needs, and risk factors of a population of focus, which is crucial for the framework of an evaluation, such as for the initial needs assessment and potential re-visitation of the assessment in a long-term evaluation (<xref rid="R15" ref-type="bibr">15</xref>). Furthermore, epidemiological methods to quantitatively measure health outcomes enable evaluators to assess the impact of the program on the health status of the population of focus, including changes in incidence, prevalence, and mortality. Increasingly, as epidemiological and data science methodologies intersect to tackle population-level questions, epidemiological data provide a reference for model parameterization (<xref rid="R16" ref-type="bibr">16</xref>). This role of epidemiological data has become important with the utilization of machine learning and statistical models (<xref rid="R1" ref-type="bibr">1</xref>) to assess &#x0201c;big data&#x0201d; and (<xref rid="R2" ref-type="bibr">2</xref>) for compartmental modeling (e.g., using administrative data to inform decision making about the results of a program evaluation and subsequent policy decisions) (<xref rid="R17" ref-type="bibr">17</xref>). Epidemiological principles shape the language of program evaluation by guiding the selection of proximal, intermediate, and distal outcomes and by focusing more broadly on the impact of a program.</p></sec><sec id="S6"><label>3.1.2</label><title>Economic Evaluation</title><p id="P13">Economic evaluation developed to inform decision making in the context of limited resources (<xref rid="R18" ref-type="bibr">18</xref>). Economic evaluation has varied definitions and forms but is generally characterized as &#x0201c;the comparative analysis of alternative courses of action of both their costs and consequences&#x0201d; (<xref rid="R19" ref-type="bibr">19</xref>). From CDC, economic evaluation is used &#x0201c;to identify, measure, value, and compare the costs and consequences of different public health [programs]&#x0201d; (<xref rid="R20" ref-type="bibr">20</xref>). Incorporating economic evaluation into program evaluation provides a systematic approach to assessing the costs associated with program implementation, including direct and indirect costs, which are vital for understanding the program&#x02019;s financial feasibility. Economic evaluation techniques like cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis enable evaluators to determine the program&#x02019;s value in terms of health outcomes relative to costs, facilitating evidence-based resource allocation decisions. As we think more critically about which programs to adopt, economic evaluation can also help model the long-term sustainability and efficiency of programs, ensuring that the benefits justify the investment and that resources are used as efficiently as possible. Economic evaluation shapes the language of program evaluation in part by focusing on costs and asking&#x02014;in a world with limited funding for programs aiming to prevent substance misuse&#x02014;how we can make decisions on the best programs to fund and what budget we need to implement them at scale.</p></sec><sec id="S7"><label>3.1.3</label><title>Implementation Science</title><p id="P14">Implementation science evolved from a demonstrated need to accelerate the slow pace with which evidence-based programs are put into practice (<xref rid="R21" ref-type="bibr">21</xref>). Implementation science provides insights into the processes by which programs are adopted, implemented, and sustained in real-world settings, which is essential for evaluating the program&#x02019;s adoption and reach, the fidelity with which it is implemented, and the extent to which it is sustained. Through a focus on barriers and facilitators to implementation, implementation science helps identify factors that influence a program&#x02019;s success (i.e., implementation determinants) and further develops and tests implementation strategies to enhance uptake and real-world effectiveness. Given the broader focus in program evaluation on sustainability, implementation science more recently has encouraged greater focus on the scalability of successful programs, ensuring that they work in pilot or controlled settings and can be effectively expanded and sustained in broader contexts.</p><p id="P15">The frameworks that are pivotal to implementation science guide the way the discipline organizes and reflects on program delivery (<xref rid="R22" ref-type="bibr">22</xref>). Commonly used theories and frameworks in implementation science include diffusion of innovations, the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) Evaluation Framework (<xref rid="R23" ref-type="bibr">23</xref>), and the Consolidated Framework for Implementation Research (<xref rid="R24" ref-type="bibr">24</xref>). In addition, the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework allows for better understanding of how implementation determinants (and thus strategies and outcomes) may vary across phases of implementation (i.e., exploration, preparation, implementation, sustainment) (<xref rid="R25" ref-type="bibr">25</xref>). Implementation science shapes the language of program evaluation through application of concepts such as tailoring to context, strategizing to overcome anticipated barriers, and scaling services with fidelity (<xref rid="R26" ref-type="bibr">26</xref>). The work of implementation science is also often mixed methods, using both qualitative and quantitative methods, with data triangulation to understand these concepts in a deeper and more comprehensive way (<xref rid="R27" ref-type="bibr">27</xref>).</p></sec></sec><sec id="S8"><label>3.2</label><title>Language Considerations</title><p id="P16">Pivotal to the application of these disciplines is the lexicon within which they operate and communicate. Those designing and conducting program evaluations also use their own lexicon. <xref rid="T2" ref-type="table">Table 2</xref> aligns key terms used by each discipline to key terms in program evaluation.</p><p id="P17"><xref rid="T2" ref-type="table">Table 2</xref> highlights how program evaluation already incorporates some important concepts from the highlighted disciplines and that, in many areas, the language is aligned across disciplines. For example, &#x0201c;fidelity&#x0201d; is a term used commonly in process evaluations and is a well-described implementation science outcome. However, some words and phrases used in the different disciplines have disparate meanings; thus, there is an opportunity to describe and provide greater clarity. For example, &#x0201c;strategy&#x0201d; can be a confusing term, given multiple meanings across disciplines. Although program evaluators may view strategies and interventions as interchangeable terms (i.e., evidence-based interventions vs. strategies), &#x0201c;strategy&#x0201d; has a very specific meaning within implementation science. An implementation strategy, defined by Proctor et al., is the &#x0201c;methods or techniques used to enhance the adoption, implementation, and sustainability of a clinical program or practice&#x0201d; (<xref rid="R32" ref-type="bibr">32</xref>). For implementation scientists, uncovering effective implementation strategies leads to strengthened delivery of a program and the potential to share those strategies as best practices with other settings considering adoption.</p><p id="P18">There are also examples of similar concepts described using different words across the disciplines. For example, the parts of an intervention, meaning the different pieces or parts that make up the intervention itself, can sometimes be referred to as &#x0201c;components.&#x0201d; In economic evaluation, costs are often measured by the &#x0201c;activities&#x0201d; involved in starting (e.g., training) or delivering (e.g., clinical supervision) the intervention. As another example, economic evaluation may use the term &#x0201c;start-up&#x0201d; costs to describe the costs related to starting a new program or putting a program &#x0201c;in place&#x0201d; before delivery of services. Implementation scientists may call these same costs preparation and implementation costs. Similarly, &#x0201c;implementation&#x0201d; in economic evaluation generally refers to what implementation science would call &#x0201c;intervention delivery.&#x0201d;</p></sec><sec id="S9"><label>3.3</label><title>Opportunities for Synergy</title><p id="P19">Finding synergy across disciplines provides opportunities to strengthen the design and application of process, outcome, and impact evaluations. <xref rid="F1" ref-type="fig">Figure 1</xref> presents a visualization of opportunities for incorporating each discipline using the CDC Evaluation Framework (<xref rid="R33" ref-type="bibr">33</xref>) as an example. This framework outlines three cross-cutting actions (engage collaboratively, learn from and use insights, and advance equity) and six steps to design and tailor an evaluation of a particular program: (<xref rid="R1" ref-type="bibr">1</xref>) assess context, (<xref rid="R2" ref-type="bibr">2</xref>) describe the program, (<xref rid="R3" ref-type="bibr">3</xref>) focus the evaluation questions and design, (<xref rid="R4" ref-type="bibr">4</xref>) gather credible evidence, (<xref rid="R5" ref-type="bibr">5</xref>) generate and support conclusions, and (<xref rid="R6" ref-type="bibr">6</xref>) act on findings. The following sections describe these steps further, with the cross-cutting principles incorporated, and demonstrates how each discipline can be leveraged. To illuminate each step in a more applied way, we use the example of evaluating a substance use screening and brief intervention (SBI) program delivered in a school-based setting. Examples from the steps are also summarized in <xref rid="T3" ref-type="table">Table 3</xref>.</p><sec id="S10"><label>3.3.1</label><title>Assess Context</title><p id="P20">The first phase of the CDC Evaluation Framework is assess context. This phase is key to program evaluation, as it ensures the subsequent phases are useful, relevant, and impactful. This is when a needs assessment might occur. Here also is when identification of relevant interested parties who will facilitate program adaptation, delivery, and evaluation is key and this may come from carrying out the needs assessment which includes collecting preliminary or previous research or engaging with key informants. In the language of implementation science, a needs assessment is an example of an exploration phase strategy that can describe the problem in need of addressing. Those conducting and describing the needs assessments to inform program selection can include, for example, members of the evaluation team, academic partners, and community representatives.</p><p id="P21">In this phase, academic partnerships with epidemiologists can help to better understand the scope of the problem using historical data for context about the disease and estimates for the potential distribution of the disease. For example, epidemiologists may provide prevalence data on adolescent risky behaviors by county, indicating potential areas of high substance use rates that require intervening. Epidemiologists can also use these data to <bold><italic toggle="yes">assist in the prioritization of programs</italic></bold> that have the most potential to address the problem at hand. Health economists can further help understand the economic burden of the problem on different sectors, investigate what causal research says about potential solutions where programs may be focused, and <bold><italic toggle="yes">assess the cost literature</italic></bold> and economic evaluation of relevant programs. Engaging epidemiologists and economists in this way can be helpful in setting the foundation for the work and aid in data-informed decision making.</p><p id="P22">Implementation science can strengthen identification and engagement of other interested or involved parties. A structured approach or model to engage interested parties or <bold><italic toggle="yes">develop partnerships</italic></bold>&#x02014;like the Center for Implementation&#x02019;s Relational Pathway&#x02014;can help to ensure an effective program evaluation (<xref rid="R34" ref-type="bibr">34</xref>). In the Relational Pathway, engagement starts with building buy-in and establishing formal and informal partnerships. For example, in the context of a school-based SBI, engagement could include holding meetings with school leaders, staff, parents, and students to discuss the need for preventing substance misuse; selecting and adapting an appropriate program; creating partnership agreements with school leadership to determine roles and responsibilities or co-creating a governance structure that could include advisory boards or work groups; establishing means of communicating within the team; and conducting informational sessions with community partners who can provide services outside the school setting to students requiring higher-intensity intervention (<xref rid="R35" ref-type="bibr">35</xref>). These partnerships may lead to more rich evaluation data conducted via qualitative interviews or surveys.</p></sec><sec id="S11"><label>3.3.2</label><title>Describe the Program</title><p id="P23">An important step before gathering evidence about a program is to describe it thoroughly. This goes beyond describing the components of the program to include the expected strategies needed to implement and maintain it. This also includes reviewing descriptives on the expected effects. Here, a logic model is helpful to guide the goals and objectives of the evaluation. Well known to program evaluators as a tool for structuring a program evaluation, logic models include the definition of critical components and where evaluation may be most pivotal for determining processes and health impact (<xref rid="R36" ref-type="bibr">36</xref>). The structure of logic models varies, but they are often made up of two sides: process and outcomes. The process side can include inputs, activities, and outputs; the outcomes include those that are short term, intermediate, and long term (<xref rid="F2" ref-type="fig">Figure 2</xref>).</p><sec id="S12"><label>3.3.2.1</label><title>Process</title><p id="P24">&#x0201c;Inputs&#x0201d; are defined as &#x0201c;resources that go into a program or intervention&#x02014;what we invest&#x0201d; (<xref rid="R37" ref-type="bibr">37</xref>). In describing the inputs of the logic model, economists in this phase can use previous research to help determine what resources may be necessary and to align with current standards of describing costs of SBI delivery. During this &#x0201c;describe the program&#x0201d; phase, epidemiology provides the foundation for the evaluation in identifying past trends and historical information, as well as any recent information such as population risk factors and the current health status of the population of focus (<xref rid="R37" ref-type="bibr">37</xref>). For example, the inputs for SBI would be consideration of the age-specific substance use risk factors and identifying resources required for a school-based SBI, including resources needed to conduct such a program in the school, such as funding, staffing to deliver SBI, and external providers to refer to.</p><p id="P25">&#x0201c;Activities&#x0201d; are &#x0201c;events undertaken by the program or partners to produce desired outcomes&#x02014;what we do&#x0201d; (<xref rid="R37" ref-type="bibr">37</xref>). Logic model activities can vary in terms of effort, timing, and importance. In addition to activities directly related to delivering SBI, implementation science can help to define and describe strategies to integrate SBI into the school. For example, an implementation strategy of training school-based health center staff to identify and intervene on risky behaviors may be listed as an activity in the logic model (<xref rid="R38" ref-type="bibr">38</xref>). Should economists choose to take an activity-based costing approach in the evaluation, activities in the logic model inform which activities are selected to cost.</p><p id="P26">&#x0201c;Outputs&#x0201d; are &#x0201c;the direct, tangible results of activities&#x02014;what we get&#x0201d; (<xref rid="R37" ref-type="bibr">37</xref>). Economists and implementation scientists can work with program evaluators to better understand and define the outputs of the SBI program by defining what the intermediate requirements are in order to achieve the primary health-related outcomes desired.</p></sec><sec id="S13"><label>3.3.2.2</label><title>Outcomes</title><p id="P27">Outcomes are defined as &#x0201c;the desired result of the program&#x02014;what we achieve&#x0201d; (<xref rid="R37" ref-type="bibr">37</xref>). Outcomes are generally distinguished by order of operation (e.g., proximal and distal) or length of time (e.g., short term, intermediate, and long term). Short-term and intermediate outcomes can be an important piece of evidence to share with interested parties, including funders and community partners, to engage collaboratively and maintain support for a program in addition to ensuring that a program is on a good track towards long-term outcomes while linking together all three.</p><p id="P28">&#x0201c;Short-term outcomes&#x0201d; are the &#x0201c;immediate effects of the program or intervention activities&#x0201d; and &#x0201c;often focus on the knowledge and attitudes of the intended audience&#x0201d; (e.g., increase in staff knowledge of substance use among youth), whereas &#x0201c;intermediate outcomes&#x0201d; are &#x0201c;behavior, normative, and policy changes&#x0201d; (e.g., increase in number of students screened) (<xref rid="R37" ref-type="bibr">37</xref>). Here is where it is important to <bold><italic toggle="yes">identify implementation outcomes</italic></bold> in describing the program. The Proctor et al. Implementation Outcomes Framework (IOF) offers short-term outcomes that are often qualitative and perception based and more aligned with exploration, like appropriateness, acceptability, and feasibility, and intermediate outcomes that are more quantitative and behavior based and aligned with implementation, such as adoption, fidelity, and reach (<xref rid="R39" ref-type="bibr">39</xref>, <xref rid="R40" ref-type="bibr">40</xref>).</p><p id="P29">&#x0201c;Long term outcomes&#x0201d; &#x0201c;refer to the desired results of the program and can take years to accomplish (<xref rid="R37" ref-type="bibr">37</xref>)&#x0201d; (e.g., reduced risk behavior among youth, reduced time to treatment referral for students with substance use disorder). These are often the primary focus of funders who are seeking observable health impacts. From epidemiology, long-term outcomes are the expected effects of the program that draw from <bold><italic toggle="yes">identified risk factors and causes of disease</italic></bold> that a program aims to address. A well-defined outcome of interest includes consideration of whether it is important to measure prevalence versus incidence and define the population of focus and the unit of analysis. Epidemiologists may provide guidance on measuring impacts (e.g., the main impact of the SBI program may be a reduced rate of substance misuse among youth). This description would be the clear specification of the outcome of interest, along with identification of the &#x0201c;problem or condition.&#x0201d; From the IOF, sustainability of the program (implementation outcome) and equity (service outcome) may be long-term outcomes of interest (<xref rid="R39" ref-type="bibr">39</xref>).</p><p id="P30">Economists, in discussion with the evaluation team, consider the best health outcomes to use as part of the economic evaluation. For example, if evaluating an SBI delivered in a school, it may be important to consider a primary health outcome of the number of days of drug use youth self-report in the past month (<xref rid="R41" ref-type="bibr">41</xref>) or perhaps a measure of health utility. The types of economic analyses planned, such as cost-effectiveness or budget impact analysis, will require using the inputs, activities, and outcomes of the logic model; these analyses occur in the next phase of focusing the evaluation design.</p></sec></sec><sec id="S14"><label>3.3.3</label><title>Focus the Evaluation Questions and Design</title><p id="P31">The focus of the evaluation questions and design builds on the phase in which the program is described. It is important to define the evaluation&#x02019;s purpose, including who will use the results and what methods will be used to carry out the evaluation. This includes developing relevant evaluation questions based on the missions and objectives of the evaluation and linking them with the methods used to provide responses to those questions. The RE-AIM framework can be used to structure and guide this process. Since its formal development and publication more than 25 years ago (<xref rid="R42" ref-type="bibr">42</xref>), program evaluators have used RE-AIM to categorize and describe the impact of their interventions. For example, an evaluation may be interested in answering what the &#x0201c;reach&#x0201d; of a program was (e.g., the number of students who receive a substance use screening at a school-based health center) and how &#x0201c;effective&#x0201d; it was (e.g., the extent to which substance misuse was reduced among students who were identified as at-risk). In this phase, implementation science methods can be used to <bold><italic toggle="yes">describe an implementation plan</italic></bold>, such as identifying via interviews or case audit who will be delivering the SBI intervention in the school setting and what are the needed implementation strategies.</p><p id="P32">Epidemiological methodology can also help inform the development of effective questions that can provide specificity and clarity to a program evaluation. Design considerations may include whether to have a comparison group (e.g., another school not implementing SBI) or a one-group design. This also ties back to having a well-defined outcome and the importance of determining the unit of analysis along with <bold><italic toggle="yes">determining the outcome data sources</italic></bold> (i.e., secondary sources when available or primary data collection).</p><p id="P33">Integrated implementation and economic evaluation plans can also occur. Economists, with input from other team members, can <bold><italic toggle="yes">develop an economic evaluation plan</italic></bold> within the larger evaluation design, including decisions about approach (e.g., taking a health care sector vs. societal analytic perspective) and plans for collecting and analyzing data as well as whether to cost the implementation strategies (&#x0201c;start-up costs&#x0201d;) in addition to intervention delivery. Some of these decisions will depend on the funding available for an economic evaluation component. For example, are resources available for a more comprehensive micro-costing approach like activity-based costing, and if so, what level of data collection burden are program deliverers willing to undertake to support such an approach? This phase includes development of data collection instruments and discussions with programmatic team members to ensure buy-in and to determine where different team members may need to collect data. For example, collection of direct and indirect cost data for an SBI in a school-based setting may be done by school administrative staff rather than the program evaluation team. Consequently, collecting these economic costs requires understanding and awareness on the part of those administrative staff responsible for providing that information (<xref rid="R43" ref-type="bibr">43</xref>). Furthermore, the methods and data for valuing resources should be specified, along with the methods and data for analyses that will be performed.</p></sec><sec id="S15"><label>3.3.4</label><title>Gather Credible Evidence</title><p id="P34">In this phase of the evaluation, evidence about the program is collected and analyzed. This extends beyond the typical focus on gathering evidence on outcomes and <bold><italic toggle="yes">identifying intervention impacts</italic></bold>; it is key to gather implementation and intervention delivery evidence using qualitative and quantitative methods. For example, <bold><italic toggle="yes">collect start-up and intervention cost data</italic></bold> during this phase. Based on the focus of the evaluation, health utility data may also be collected in this phase. The economic evaluation team needs to provide support, and in some cases, conduct qualitative interviews, to ensure data collected are accurate and consistent. Secondary data or reviews of relevant literature may be conducted during this phase as necessary for analyses. For example, if a societal perspective is used, costs from other sectors, such as the youth legal system or other social service settings, may be needed. If the analysis uses a modeling approach, the model and associated input parameters can be built in this phase.</p><p id="P35">There is also a great opportunity for synergy between implementation science and economic evaluation when activity-based costing is undertaken. Implementation science methods can facilitate the detailing and description of each intervention component as part of this phase of describing the program, and in turn, this information is helpful for providing context on the activities measured for cost purposes. Furthermore, <bold><italic toggle="yes">tracking program adaptations</italic></bold> can help to understand why certain outcomes were or were not achieved. The Framework for Reporting Adaptations and Modifications-Enhanced (FRAME) is one tool from implementation science that can help guide this effort (<xref rid="R44" ref-type="bibr">44</xref>). It encourages thinking around when in the process the modification was made, whether a modification was planned/proactive or unplanned/reactive, who determined the modification was needed, what was modified and at what level (e.g., content of the substance use screener was modified at the individual student level vs. for all students at the school level), the nature of the modification (e.g., added screening elements), whether the modification is fidelity-consistent, and the reasons for the modification. Tools like this can help organize important information collected qualitatively about program delivery in dynamic real-world settings.</p></sec><sec id="S16"><label>3.3.5</label><title>Generate and Support Conclusions</title><p id="P36">After gathering credible evidence, interpretation of the evidence is required. Results should provide answers to the evaluation questions along with the level of statistical confidence. If collected, supporting qualitative data (e.g., details of and perspectives on program activities and impacts) can provide a richer understanding of results and, for example, the acceptability of the program among practitioners in addition to those receiving it or unplanned adaptations during program delivery that change core components. This can support <bold><italic toggle="yes">interpretation of outcomes achieved in light of implementation outcomes</italic>.</bold> The findings based on decisions made in the earlier phases of describing the program and focusing the evaluation will be pivotal for the justification of conclusions. Strong application of epidemiologic and economic methods is needed to appropriately analyze the data, following the specified methodological plan. Conclusions should be based on the results, including results from any sensitivity analyses. These conclusions will inform any resulting program recommendations.</p></sec><sec id="S17"><label>3.3.6</label><title>Act on Findings</title><p id="P37">Ultimately, program evaluation requires a focus on effectively disseminating results and lessons learned. Throughout the phases of the program evaluation process, engagement with the primary users (i.e., the recipients of the program and the evaluation results) is needed to ensure its utility. Sharing evaluation results and lessons involves considering the format in which information will be communicated and how it will be tailored for different audiences. Here, there is an opportunity to have cross-disciplinary dissemination that pairs epidemiological, economic evaluation, and implementation results. Epidemiologic methods can identify causes of disease, along with associations and potential solutions that can help inform policy and public health decisions. Within implementation science, methods of effective dissemination can inform this phase; these methods include the cross-cutting action of &#x0201c;engage collaboratively&#x0201d; with an analysis of those parties, their roles, and the preferred communication methods. For example, the results of the evaluation of the school-based SBI program may require engagement with policymakers around financing strategies and opportunities for becoming part of a payment schedule to be covered by health insurance (<xref rid="R45" ref-type="bibr">45</xref>).</p></sec></sec></sec><sec id="S18"><label>4</label><title>Conclusions</title><p id="P38">Program evaluation is a key element to ensuring that implementation of evidence-based programs is effectively delivered and achieves intended impacts in the real world. Leveraging epidemiology, economic evaluation, and implementation science establishes a stronger multidimensional approach to address the &#x0201c;what works,&#x0201d; &#x0201c;how,&#x0201d; &#x0201c;for whom,&#x0201d; and &#x0201c;at what cost&#x0201d; aspects of program evaluation.</p><p id="P39">Epidemiology clarifies what programs need to address and whether a program works (is effective) by providing data on health problems, risks, and outcomes to guide the focus of the program evaluation. Economic evaluation assesses at what cost the program achieves its outcomes, offering a critical perspective on the program&#x02019;s value, which is essential for comprehensive outcome evaluation. Implementation science delves into how practitioners implement the program, identifying strategies to enhance adoption, fidelity, reach, and sustainability, thereby informing the process evaluation component. Economic evaluation and implementation science are critical for dissemination by providing start-up and intervention information beyond effectiveness, including costs, that can inform when a program is scaled up.</p><p id="P40">The relationship between these concepts and program evaluation can be synergistic, with each contributing unique insights that collectively provide a thorough approach to assessing and improving efforts to address priority problems such as substance misuse. In this article, we aim to demonstrate ways in which program evaluators can engage these disciplines; communication and collaboration across disciplines can help identify ways to optimize limited resources, strengthen methods, and improve synthesis. For example, evaluation teams can strengthen the integration of implementation science and economic evaluation by agreeing on the start-up and other implementation activities versus program activities (<xref rid="R7" ref-type="bibr">7</xref>).</p><p id="P41">Funding for program evaluation is often limited, further challenging the inclusion of these different disciplines. Without additional funding for program evaluation, consideration is needed for how to include these disciplines without overwhelming project budgets. From an epidemiologic perspective, secondary data can also be a useful solution when the population is over-surveyed or experiencing survey fatigue. For example, the economic evaluation will require engaging an economist on the team, but some approaches to costing, such as using secondary data, can be less resource intensive. In other cases where an economist cannot be supported, efforts to collect cost data are still valuable; these data would allow for follow-up economic evaluation studies. For implementation-related questions, program evaluators can use existing literature and resources on basic implementation science concepts that are most helpful in designing the process components of an evaluation. Specifically, skills in how to identify and measure implementation outcomes (<xref rid="R46" ref-type="bibr">46</xref>) can provide a great deal of support in the early steps of program evaluation.</p><p id="P42">This article was supported by the Helping to End Addiction Long-term (HEAL) Initiative<sup>&#x000ae;</sup> launched by the National Institutes of Health in 2018. Through this initiative, the National Institute on Drug Abuse administered the HEAL Preventing Opioid Use Disorder (OUD) research program to focus specifically on identifying effective upstream prevention interventions. Within this program, the HEAL Prevention Cooperative is composed of 10 research projects testing interventions to prevent opioid misuse or escalation to OUD among youth and young adults in real-world settings, along with the HEAL Prevention Coordinating Center (HPCC). The HPCC learned many lessons regarding the need to integrate and align epidemiological outcomes, implementation measures, and cost data collection regardless of delivery setting. Understanding the processes for evaluating a program can lead to better program descriptions, result in faster development of an evidence base for a program, and accelerate the pace with which programs become part of routine practice (<xref rid="R47" ref-type="bibr">47</xref>). An integrated approach ensures that program evaluations are not only comprehensive in scope but also practical in informing future practice to improve health outcomes at a population level. Integrating the principles of epidemiology, economic evaluation, and implementation science into program evaluation not only enriches the assessment process but also establishes a comprehensive framework that addresses the multifaceted and complex nature of programs to prevent substance misuse.</p></sec></body><back><ack id="S19"><title>Acknowledgments</title><p id="P46">We would like to thank those who participated in a workshop on this topic at the Society for Prevention Research 32nd Annual Meeting.</p><sec id="S20"><title>Funding</title><p id="P47">This work is supported by the National Institutes of Health (NIH) through the NIH Helping to End Addiction Long-term<sup>&#x000ae;</sup> Initiative (HEAL Initiative<sup>&#x000ae;</sup>) as part of the HEAL Preventing Opioid Use Disorder Research Program U24DA050182. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH.</p></sec></ack><fn-group><fn id="FN5"><p id="P48" content-type="publisher-disclaimer">This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p></fn><fn fn-type="COI-statement" id="FN6"><p id="P49">Declaration of Competing Interest</p><p id="P50">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></fn><fn id="FN7"><p id="P51">Ethics Approval and Consent to Participate</p><p id="P52">Given the nature of the article, neither ethical approval from the authors&#x02019; institutions nor informed consent from participants was necessary.</p></fn></fn-group><sec sec-type="data-availability" id="S180"><title>Availability of Data and Materials</title><p id="P250">Data sharing is not applicable to this article, as no datasets were generated or analyzed during the current study.</p></sec><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>CDC Approach to Program Evaluation</source>
<year>2024</year> [updated <month>August</month>
<day>18</day>. Available from: <ext-link xlink:href="https://www.cdc.gov/evaluation/php/about/index.html" ext-link-type="uri">https://www.cdc.gov/evaluation/php/about/index.html</ext-link>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Spiegelman</surname><given-names>D</given-names></name>. <article-title>Evaluating public health interventions: 1. Examples, definitions, and a personal note</article-title>. <source>Am J Public Health</source>. <year>2016</year>;<volume>106</volume>(<issue>1</issue>):<fpage>70</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">26562122</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>ML</given-names></name>, <name><surname>Ory</surname><given-names>MG</given-names></name>. <article-title>Measuring success: evaluation article types for the public health education and promotion section of frontiers in public health</article-title>. <source>Front Public Health</source>. <year>2014</year>;<volume>2</volume>:<fpage>111</fpage>.<pub-id pub-id-type="pmid">25165688</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Powell</surname><given-names>BJ</given-names></name>, <name><surname>Waltz</surname><given-names>TJ</given-names></name>, <name><surname>Chinman</surname><given-names>MJ</given-names></name>, <name><surname>Damschroder</surname><given-names>LJ</given-names></name>, <name><surname>Smith</surname><given-names>JL</given-names></name>, <name><surname>Matthieu</surname><given-names>MM</given-names></name>, <etal/>
<article-title>A refined compilation of implementation strategies: Results from the Expert Recommendations for Implementing Change (ERIC) project</article-title>. <source>Implement Sci</source>. <year>2015</year>;<volume>10</volume>(<issue>1</issue>):<fpage>21</fpage>.<pub-id pub-id-type="pmid">25889199</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="book"><name><surname>Drummond</surname><given-names>ME</given-names></name>, <name><surname>Sculpher</surname><given-names>MJ</given-names></name>, <name><surname>Torrance</surname><given-names>GW</given-names></name>, <name><surname>O&#x02019;Brien</surname><given-names>BJ</given-names></name>, <name><surname>Stoddart</surname><given-names>GL</given-names></name>. <source>Methods for the Economic Evaluation of Health Care Programmes</source>: <publisher-name>Oxford University Press</publisher-name>; <year>2005</year>
<date-in-citation>31 Oct 2023</date-in-citation>.</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Sanders</surname><given-names>GD</given-names></name>, <name><surname>Neumann</surname><given-names>PJ</given-names></name>, <name><surname>Basu</surname><given-names>A</given-names></name>, <name><surname>Brock</surname><given-names>DW</given-names></name>, <name><surname>Feeny</surname><given-names>D</given-names></name>, <name><surname>Krahn</surname><given-names>M</given-names></name>, <etal/>
<article-title>Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second panel on cost-effectiveness in health and medicine</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>316</volume>(<issue>10</issue>):<fpage>1093</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">27623463</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Malhotra</surname><given-names>A</given-names></name>, <name><surname>Thompson</surname><given-names>RR</given-names></name>, <name><surname>Kagoya</surname><given-names>F</given-names></name>, <name><surname>Masiye</surname><given-names>F</given-names></name>, <name><surname>Mbewe</surname><given-names>P</given-names></name>, <name><surname>Mosepele</surname><given-names>M</given-names></name>, <etal/>
<article-title>Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review</article-title>. <source>Implement Sci</source>. <year>2022</year>;<volume>17</volume>(<issue>1</issue>):<fpage>76</fpage>.<pub-id pub-id-type="pmid">36384807</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Roberts</surname><given-names>SLE</given-names></name>, <name><surname>Healey</surname><given-names>A</given-names></name>, <name><surname>Sevdalis</surname><given-names>N</given-names></name>. <article-title>Use of health economic evaluation in the implementation and improvement science fields-a systematic literature review</article-title>. <source>Implement Sci</source>. <year>2019</year>;<volume>14</volume>(<issue>1</issue>):<fpage>72</fpage>.<pub-id pub-id-type="pmid">31307489</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Krebs</surname><given-names>E</given-names></name>, <name><surname>Nosyk</surname><given-names>B</given-names></name>. <article-title>Cost-effectiveness analysis in implementation science: A research agenda and call for wider application</article-title>. <source>Curr HIV/AIDS Rep</source>. <year>2021</year>;<volume>18</volume>(<issue>3</issue>):<fpage>176</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">33743138</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Milstein</surname><given-names>B</given-names></name>, <name><surname>Wetterhall</surname><given-names>SF</given-names></name>. <article-title>Framework for program evaluation in public health</article-title>. . <source>MMWR Recomm Rep</source>. <year>1999</year>;<volume>48</volume>(<issue>RR-11</issue>):<fpage>1</fpage>&#x02013;<lpage>40</lpage>.</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Kidder</surname><given-names>DP</given-names></name>, <name><surname>Fierro</surname><given-names>LA</given-names></name>, <name><surname>Luna</surname><given-names>E</given-names></name>, <name><surname>Salvaggio</surname><given-names>H</given-names></name>, <name><surname>McWhorter</surname><given-names>A</given-names></name>, <name><surname>Bowen</surname><given-names>S-A</given-names></name>, <etal/>
<article-title>CDC program evaluation framework, 2024</article-title>. <source>MMWR Recomm Rep</source>. <year>2024</year>;<volume>73</volume>(<issue>6</issue>):<fpage>1</fpage>&#x02013;<lpage>37</lpage>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>CDC program evaluation framework</source>
<year>2024</year> [updated <month>August</month>
<day>20</day>. Available from: <ext-link xlink:href="https://www.cdc.gov/evaluation/php/evaluation-framework/index.html" ext-link-type="uri">https://www.cdc.gov/evaluation/php/evaluation-framework/index.html</ext-link>.</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="book"><source>Foundations Of Epidemiology</source>. <name><surname>Lilienfeld</surname><given-names>DE</given-names></name>, <name><surname>Stolley</surname><given-names>PD</given-names></name>, <name><surname>Lilienfeld</surname><given-names>AM</given-names></name>, editors: <publisher-name>Oxford University Press</publisher-name>; <year>1994</year>
<date-in-citation>31 Oct 2023</date-in-citation>.</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Frerot</surname><given-names>M</given-names></name>, <name><surname>Lefebvre</surname><given-names>A</given-names></name>, <name><surname>Aho</surname><given-names>S</given-names></name>, <name><surname>Callier</surname><given-names>P</given-names></name>, <name><surname>Astruc</surname><given-names>K</given-names></name>, <name><surname>Aho Glele</surname><given-names>LS</given-names></name>. <article-title>What is epidemiology? Changing definitions of epidemiology 1978&#x02013;2017</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>12</issue>):<fpage>e0208442</fpage>.<pub-id pub-id-type="pmid">30532230</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Antoniadis</surname><given-names>A</given-names></name>, <name><surname>Lubker</surname><given-names>BB</given-names></name>. <article-title>Epidemiology as an essential tool for establishing prevention programs and evaluating their impact and outcome</article-title>. <source>J Commun Disord</source>. <year>1997</year>;<volume>30</volume>(<issue>4</issue>):<fpage>269</fpage>&#x02013;<lpage>83</lpage>; quiz 83&#x02013;4.<pub-id pub-id-type="pmid">9208363</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Fairchild</surname><given-names>G</given-names></name>, <name><surname>Tasseff</surname><given-names>B</given-names></name>, <name><surname>Khalsa</surname><given-names>H</given-names></name>, <name><surname>Generous</surname><given-names>N</given-names></name>, <name><surname>Daughton</surname><given-names>AR</given-names></name>, <name><surname>Velappan</surname><given-names>N</given-names></name>, <etal/>
<article-title>Epidemiological data challenges: Planning for a more robust future through data standards</article-title>. <source>Front Public Health</source>. <year>2018</year>;<volume>6</volume>:<fpage>336</fpage>.<pub-id pub-id-type="pmid">30533407</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Zanti</surname><given-names>S</given-names></name>, <name><surname>Berkowitz</surname><given-names>E</given-names></name>, <name><surname>Katz</surname><given-names>M</given-names></name>, <name><surname>Nelson</surname><given-names>AH</given-names></name>, <name><surname>Burnett</surname><given-names>TC</given-names></name>, <name><surname>Culhane</surname><given-names>D</given-names></name>, <etal/>
<article-title>Leveraging integrated data for program evaluation: Recommendations from the field</article-title>. <source>Eval Program Plann</source>. <year>2022</year>;<volume>95</volume>:<fpage>102093</fpage>.<pub-id pub-id-type="pmid">36027757</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Goodacre</surname><given-names>S</given-names></name>, <name><surname>McCabe</surname><given-names>C</given-names></name>. <article-title>An introduction to economic evaluation</article-title>. <source>Emerg Med J</source>. <year>2002</year>;<volume>19</volume>(<issue>3</issue>):<fpage>198</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">11971826</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="book"><name><surname>Drummond</surname><given-names>MF</given-names></name>, <name><surname>Sculpher</surname><given-names>MJ</given-names></name>, <name><surname>Claxton</surname><given-names>K</given-names></name>, <name><surname>Stoddart</surname><given-names>GL</given-names></name>, <name><surname>Torrance</surname><given-names>GW</given-names></name>. <source>Methods for the Economic Evaluation of Health Care Programmes</source>. <edition>4th ed</edition>: <publisher-name>Oxford University Press</publisher-name>; <year>2015</year>.</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab>. <source>Economic evaluation overview</source>
<publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>; <year>2021</year> [updated <month>March</month>
<day>3</day>. Available from: <ext-link xlink:href="https://www.cdc.gov/policy/polaris/economics/index.html" ext-link-type="uri">https://www.cdc.gov/policy/polaris/economics/index.html</ext-link>.</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>ZS</given-names></name>, <name><surname>Wooding</surname><given-names>S</given-names></name>, <name><surname>Grant</surname><given-names>J</given-names></name>. <article-title>The answer is 17 years, what is the question: understanding time lags in translational research</article-title>. <source>J R Soc Med</source>. <year>2011</year>;<volume>104</volume>(<issue>12</issue>):<fpage>510</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">22179294</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Nilsen</surname><given-names>P</given-names></name>. <article-title>Making sense of implementation theories, models and frameworks</article-title>. <source>Implement Sci</source>. <year>2015</year>;<volume>10</volume>:<fpage>53</fpage>.<pub-id pub-id-type="pmid">25895742</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Glasgow</surname><given-names>RE</given-names></name>, <name><surname>Harden</surname><given-names>SM</given-names></name>, <name><surname>Gaglio</surname><given-names>B</given-names></name>, <name><surname>Rabin</surname><given-names>B</given-names></name>, <name><surname>Smith</surname><given-names>ML</given-names></name>, <name><surname>Porter</surname><given-names>GC</given-names></name>, <etal/>
<article-title>RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review</article-title>. <source>Front Public Health</source>. <year>2019</year>;<volume>7</volume>:<fpage>64</fpage>.<pub-id pub-id-type="pmid">30984733</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Damschroder</surname><given-names>LJ</given-names></name>, <name><surname>Reardon</surname><given-names>CM</given-names></name>, <name><surname>Widerquist</surname><given-names>MAO</given-names></name>, <name><surname>Lowery</surname><given-names>J</given-names></name>. <article-title>The updated Consolidated Framework for Implementation Research based on user feedback</article-title>. <source>Implement Sci</source>. <year>2022</year>;<volume>17</volume>(<issue>1</issue>):<fpage>75</fpage>.<pub-id pub-id-type="pmid">36309746</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Aarons</surname><given-names>GA</given-names></name>, <name><surname>Hurlburt</surname><given-names>M</given-names></name>, <name><surname>Horwitz</surname><given-names>SM</given-names></name>. <article-title>Advancing a conceptual model of evidence-based practice implementation in public service sectors</article-title>. <source>Adm Policy Ment Health</source>. <year>2011</year>;<volume>38</volume>(<issue>1</issue>):<fpage>4</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">21197565</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Rabin</surname><given-names>BA</given-names></name>, <name><surname>Brownson</surname><given-names>RC</given-names></name>, <name><surname>Haire-Joshu</surname><given-names>D</given-names></name>, <name><surname>Kreuter</surname><given-names>MW</given-names></name>, <name><surname>Weaver</surname><given-names>NL</given-names></name>. <article-title>A glossary for dissemination and implementation research in health</article-title>. <source>J Public Health Manag Pract</source>. <year>2008</year>;<volume>14</volume>(<issue>2</issue>):<fpage>117</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">18287916</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="book"><name><surname>Palinkas</surname><given-names>LA</given-names></name>, <name><surname>Cooper</surname><given-names>BR</given-names></name>. <part-title>Mixed methods evaluation in dissemination and implementation science</part-title>. In: <name><surname>Brownson</surname><given-names>RC</given-names></name>, <name><surname>Colditz</surname><given-names>GA</given-names></name>, <name><surname>Proctor</surname><given-names>EK</given-names></name>, editors. <source>Dissemination and implementation research in health: Translating science to practice</source>. <edition>2nd ed</edition>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2017</year>. p. <fpage>335</fpage>&#x02013;<lpage>54</lpage>.</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Eccles</surname><given-names>MP</given-names></name>, <name><surname>Mittman</surname><given-names>BS</given-names></name>. <article-title>Welcome to Implementation Science</article-title>. <source>Implement Sci</source>. <year>2006</year>;<volume>1</volume>(<issue>1</issue>):<fpage>1</fpage>.</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>von Elm</surname><given-names>E</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Egger</surname><given-names>M</given-names></name>, <name><surname>Pocock</surname><given-names>SJ</given-names></name>, <name><surname>Gotzsche</surname><given-names>PC</given-names></name>, <name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>, <etal/>
<article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies</article-title>. <source>Int J Surg</source>. <year>2014</year>;<volume>12</volume>(<issue>12</issue>):<fpage>1495</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">25046131</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Husereau</surname><given-names>D</given-names></name>, <name><surname>Drummond</surname><given-names>M</given-names></name>, <name><surname>Augustovski</surname><given-names>F</given-names></name>, <name><surname>de Bekker-Grob</surname><given-names>E</given-names></name>, <name><surname>Briggs</surname><given-names>AH</given-names></name>, <name><surname>Carswell</surname><given-names>C</given-names></name>, <etal/>
<article-title>Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations</article-title>. <source>Value Health</source>. <year>2022</year>;<volume>25</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">35031096</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Hoffmann</surname><given-names>TC</given-names></name>, <name><surname>Glasziou</surname><given-names>PP</given-names></name>, <name><surname>Boutron</surname><given-names>I</given-names></name>, <name><surname>Milne</surname><given-names>R</given-names></name>, <name><surname>Perera</surname><given-names>R</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name>, <etal/>
<article-title>Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide</article-title>. <source>BMJ</source>. <year>2014</year>;<volume>348</volume>:<fpage>g1687</fpage>.<pub-id pub-id-type="pmid">24609605</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Proctor</surname><given-names>EK</given-names></name>, <name><surname>Powell</surname><given-names>BJ</given-names></name>, <name><surname>McMillen</surname><given-names>JC</given-names></name>. <article-title>Implementation strategies: recommendations for specifying and reporting</article-title>. <source>Implement Sci</source>. <year>2013</year>;<volume>8</volume>(<issue>1</issue>):<fpage>139</fpage>.<pub-id pub-id-type="pmid">24289295</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="book"><collab>Centers for Disease Control and Prevention</collab>. <source>A framework for program evaluation</source>
<publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>; <year>2017</year> [updated <month>May</month>
<day>15</day>. Available from: <ext-link xlink:href="https://www.cdc.gov/evaluation/framework/index.htm" ext-link-type="uri">https://www.cdc.gov/evaluation/framework/index.htm</ext-link>.</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="webpage"><name><surname>Moore</surname><given-names>J</given-names></name>, <name><surname>Khan</surname><given-names>S</given-names></name>. <source>Toronto, Ontario: The Center for Implementation</source>. <year>2022</year>. [cited 2022]. Available from: <ext-link xlink:href="https://www.linkedin.com/pulse/considering-role-relationships-implement" ext-link-type="uri">https://www.linkedin.com/pulse/considering-role-relationships-implement</ext-link>&#x02026;; .</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Maslowsky</surname><given-names>J</given-names></name>, <name><surname>Whelan Capell</surname><given-names>J</given-names></name>, <name><surname>Moberg</surname><given-names>DP</given-names></name>, <name><surname>Brown</surname><given-names>RL</given-names></name>. <article-title>Universal school-based implementation of Screening Brief Intervention and Referral to Treatment to reduce and prevent alcohol, marijuana, tobacco, and other drug use: process and feasibility</article-title>. <source>Subst Abuse</source>. <year>2017</year>;<volume>11</volume>:1178221817746668.</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="book"><name><surname>Frechtling</surname><given-names>JA</given-names></name>. <source>Logic modeling methods in program evaluation</source>. <publisher-loc>Hoboken, NJ, US</publisher-loc>: <publisher-name>Jossey-Bass/Wiley</publisher-name>; <year>2007</year>. <volume>xiii</volume>, <fpage>146</fpage>&#x02013;<lpage>xiii</lpage>, p.</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="book"><collab>State Heart Disease and Stroke Prevention Program</collab>. <source>Evaluation guide: developing and using a logic model</source>. <publisher-loc>Atlanta, GA</publisher-loc>: <publisher-name>CDC Division for Heart Disease and Stroke Prevention</publisher-name>.</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Ramos</surname><given-names>MM</given-names></name>, <name><surname>Sebastian</surname><given-names>RA</given-names></name>, <name><surname>Murphy</surname><given-names>M</given-names></name>, <name><surname>Oreskovich</surname><given-names>K</given-names></name>, <name><surname>Condon</surname><given-names>TP</given-names></name>. <article-title>Adolescent substance use: assessing the knowledge, attitudes, and practices of a school-based health center workforce</article-title>. <source>Substance Abuse</source>. <year>2017</year>;<volume>38</volume>(<issue>2</issue>):<fpage>230</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">28328312</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Proctor</surname><given-names>E</given-names></name>, <name><surname>Silmere</surname><given-names>H</given-names></name>, <name><surname>Raghavan</surname><given-names>R</given-names></name>, <name><surname>Hovmand</surname><given-names>P</given-names></name>, <name><surname>Aarons</surname><given-names>G</given-names></name>, <name><surname>Bunger</surname><given-names>A</given-names></name>, <etal/>
<article-title>Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda</article-title>. <source>Adm Policy Ment Health</source>. <year>2011</year>;<volume>38</volume>(<issue>2</issue>):<fpage>65</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">20957426</pub-id>
</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Reilly</surname><given-names>KL</given-names></name>, <name><surname>Kennedy</surname><given-names>S</given-names></name>, <name><surname>Porter</surname><given-names>G</given-names></name>, <name><surname>Estabrooks</surname><given-names>P</given-names></name>. <article-title>Comparing, Contrasting, and Integrating Dissemination and Implementation Outcomes Included in the RE-AIM and Implementation Outcomes Frameworks</article-title>. <source>Front Public Health</source>. <year>2020</year>;<volume>8</volume>:<fpage>430</fpage>.<pub-id pub-id-type="pmid">32984239</pub-id>
</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>SG</given-names></name>, <name><surname>Gryczynski</surname><given-names>J</given-names></name>, <name><surname>Gonzales</surname><given-names>A</given-names></name>, <name><surname>Moseley</surname><given-names>A</given-names></name>, <name><surname>Peterson</surname><given-names>T</given-names></name>, <name><surname>O&#x02019;Grady</surname><given-names>KE</given-names></name>, <etal/>
<article-title>Screening, Brief Intervention, and Referral to Treatment (SBIRT) for substance use in a school-based program: services and outcomes</article-title>. <source>Am J Addict</source>. <year>2012</year>;<volume>21</volume> Suppl 1(<issue>0 1</issue>):<fpage>S5</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">23786511</pub-id>
</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Glasgow</surname><given-names>RE</given-names></name>, <name><surname>Vogt</surname><given-names>TM</given-names></name>, <name><surname>Boles</surname><given-names>SM</given-names></name>. <article-title>Evaluating the public health impact of health promotion interventions: the RE-AIM framework</article-title>. <source>Am J Public Health</source>. <year>1999</year>;<volume>89</volume>(<issue>9</issue>):<fpage>1322</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">10474547</pub-id>
</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="other"><name><surname>Bray</surname><given-names>JW</given-names></name>, <name><surname>Mallonee</surname><given-names>E</given-names></name>, <name><surname>Dowd</surname><given-names>WN</given-names></name>, <name><surname>Aldridge</surname><given-names>AP</given-names></name>, <name><surname>Cowell</surname><given-names>AJ</given-names></name>, <name><surname>Vendetti</surname><given-names>J</given-names></name>, editors. <source>Program- and service-level costs of seven screening, brief intervention, and referral to treatment programs2014</source>.</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Wiltsey Stirman</surname><given-names>S</given-names></name>, <name><surname>Baumann</surname><given-names>AA</given-names></name>, <name><surname>Miller</surname><given-names>CJ</given-names></name>. <article-title>The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions</article-title>. <source>Implement Sci</source>. <year>2019</year>;<volume>14</volume>(<issue>1</issue>).</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Reif</surname><given-names>S</given-names></name>, <name><surname>Brolin</surname><given-names>M</given-names></name>, <name><surname>Beyene</surname><given-names>TM</given-names></name>, <name><surname>D&#x02019;Agostino</surname><given-names>N</given-names></name>, <name><surname>Stewart</surname><given-names>MT</given-names></name>, <name><surname>Horgan</surname><given-names>CM</given-names></name>. <article-title>Payment and financing for substance use screening and brief intervention for adolescents and adults in health, school, and community settings</article-title>. <source>J Adolesc Health</source>. <year>2022</year>;<volume>71</volume>(<issue>4s</issue>):<fpage>S73</fpage>&#x02013;<lpage>s82</lpage>.<pub-id pub-id-type="pmid">36122974</pub-id>
</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Proctor</surname><given-names>EK</given-names></name>, <name><surname>Bunger</surname><given-names>AC</given-names></name>, <name><surname>Lengnick-Hall</surname><given-names>R</given-names></name>, <name><surname>Gerke</surname><given-names>DR</given-names></name>, <name><surname>Martin</surname><given-names>JK</given-names></name>, <name><surname>Phillips</surname><given-names>RJ</given-names></name>, <etal/>
<article-title>Ten years of implementation outcomes research: a scoping review</article-title>. <source>Implement Sci</source>. <year>2023</year>;<volume>18</volume>(<issue>1</issue>):<fpage>31</fpage>.<pub-id pub-id-type="pmid">37491242</pub-id>
</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="webpage"><collab>Department of Health and Human Services</collab>. <source>The Helping to End Addiction Long-term Initiative: supporting science-based solutions to the opioid crisis</source>
<year>2023</year> [Available from: <ext-link xlink:href="https://heal.nih.gov/" ext-link-type="uri">https://heal.nih.gov/</ext-link>.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P53">Incorporating epidemiology, implementation science, and economic evaluation into the steps of program evaluation</p></caption><graphic xlink:href="nihms-2085686-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p id="P54">CDC layout of a general logic model</p><p id="P540">Sources: CDC Division for Heart Disease and Stroke Prevention. n.d. <italic toggle="yes">Evaluation Guide: Developing and Using a Logic Model</italic>. <ext-link xlink:href="https://www.cdc.gov/cardiovascular-resources/media/pdfs/logic_model.pdf" ext-link-type="uri">https://www.cdc.gov/cardiovascular-resources/media/pdfs/logic_model.pdf</ext-link>; CDC Office of Policy, Performance, and Evaluation. 2018. <italic toggle="yes">Program Evaluation Framework Checklist for Step 2</italic>. <ext-link xlink:href="https://www.cdc.gov/evaluation/steps/step2/index.htm" ext-link-type="uri">https://www.cdc.gov/evaluation/steps/step2/index.htm</ext-link></p></caption><graphic xlink:href="nihms-2085686-f0002" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1.</label><caption><p id="P43">Summary of disciplines</p></caption><table frame="box" rules="rows"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Program Evaluation in Public Health</th><th align="center" valign="bottom" rowspan="1" colspan="1">Epidemiology</th><th align="center" valign="bottom" rowspan="1" colspan="1">Economic Evaluation</th><th align="center" valign="bottom" rowspan="1" colspan="1">Implementation Science</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Definitions</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0201c;The systematic investigation of the merit, worth, or significance of an object. &#x0201d; (<xref rid="R1" ref-type="bibr">1</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0201c;Epidemiology is the study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems&#x0201d; (<xref rid="R14" ref-type="bibr">14</xref>).</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0201c;The comparative analysis of alternative courses of action of both their costs and consequences&#x0201d; (<xref rid="R5" ref-type="bibr">5</xref>).</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0201c;The scientific study of methods to promote the systematic uptake of research findings and other evidence-based practices into routine practice, and, hence, to improve the quality and effectiveness of health services&#x0201d; (<xref rid="R28" ref-type="bibr">28</xref>).</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Origins</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Psychology, Education, Curricula Assessments</td><td align="left" valign="top" rowspan="1" colspan="1">Medicine, Germ Theory, John Snow, Mathematics</td><td align="left" valign="top" rowspan="1" colspan="1">Health economics, Political Science, Economic theory</td><td align="left" valign="top" rowspan="1" colspan="1">Rogers Diffusion of Innovation, Kingdon&#x02019;s Policy Streams, Knowledge Translation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Key elements or features within program evaluation</italic>
</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>-</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Measurement of morbidity and mortality of a population; measurement of the determinants of morbidity and mortality.</td><td align="left" valign="top" rowspan="1" colspan="1">Analysis of cost and outcomes.<break/>Comparative assessment of program value (i.e., requires a comparator).</td><td align="left" valign="top" rowspan="1" colspan="1">Measurement of adoption, reach, and sustainment of programs.<break/>Development and assessment of strategies for implementing programs.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Example publication</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">American Evaluation Association</td><td align="left" valign="top" rowspan="1" colspan="1">Strengthening Reporting in Observational Studies</td><td align="left" valign="top" rowspan="1" colspan="1">Consolidated Health Economic Evaluation</td><td align="left" valign="top" rowspan="1" colspan="1">Template for Intervention Description and Replication</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">reporting standards</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Guiding Principles for Evaluators</td><td align="left" valign="top" rowspan="1" colspan="1">in Epidemiology (STROBE) (<xref rid="R29" ref-type="bibr">29</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">Reporting Standards (CHEERS) (<xref rid="R30" ref-type="bibr">30</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">(TIDieR), Standards for Reporting Implementation Studies (StaRI) (<xref rid="R31" ref-type="bibr">31</xref>)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P44">Select program evaluation terms&#x02014;crosswalk of overlapping and diverging language applied across disciplines</p></caption><table frame="box" rules="rows"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Program Evaluation Term</th><th align="center" valign="bottom" rowspan="1" colspan="1">Epidemiology</th><th align="center" valign="bottom" rowspan="1" colspan="1">Economic Evaluation</th><th align="center" valign="bottom" rowspan="1" colspan="1">Implementation Science</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Program</italic>
</bold>
<break/>
<bold>
<italic toggle="yes">Strategy</italic>
</bold>
<break/>
<bold>
<italic toggle="yes">Intervention</italic>
</bold>
<break/>
<bold>
<italic toggle="yes">Evidence-based or -informed intervention, strategy, or practice</italic>
</bold>
<break/>
<bold>
<italic toggle="yes">Program activities</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Strategies Exposure</td><td align="left" valign="top" rowspan="1" colspan="1">Intervention Program</td><td align="left" valign="top" rowspan="1" colspan="1">Innovation<break/>Evidence-based Intervention or Practice<break/>7 P&#x02019;s: pills, programs, practices, principles, products, policies, procedures<break/>Core vs. peripheral components</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>-</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>-</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Start-up</td><td align="left" valign="top" rowspan="1" colspan="1">Pre-implementation strategies<break/>Implementation strategies<break/>Sustainment strategies</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Setting</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Setting, descriptives</td><td align="left" valign="top" rowspan="1" colspan="1">Setting</td><td align="left" valign="top" rowspan="1" colspan="1">Implementation context<break/>Inner/internal setting (characteristics of the delivery setting)<break/>Outer/external setting (characteristics of the broader environment)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Program adaptation, modification</italic>
</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>-</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>-</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Adaptation<break/>Tailoring<break/>Planned/unplanned modification</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Costs Resources</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Start-up costs<break/>Adaptation costs<break/>Intervention costs<break/>Opportunity cost<break/>Marginal cost<break/>Indirect and direct costs<break/>Fixed and variable costs</td><td align="left" valign="top" rowspan="1" colspan="1">Implementation cost<break/>Staffing needs<break/>Infrastructure needs<break/>Cost impact</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Implementation</italic>
</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>-</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Start-up period<break/>Implementation period</td><td align="left" valign="top" rowspan="1" colspan="1">Preparation phase<break/>Adoption<break/>Implementation phase<break/>Initial implementation<break/>Uptake<break/>Spread/scale</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Fidelity</italic>
</bold>
<break/>
<bold>
<italic toggle="yes">Quality of program delivery</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Adherence</td><td align="left" valign="top" rowspan="1" colspan="1">Fidelity</td><td align="left" valign="top" rowspan="1" colspan="1">Fidelity<break/>Quality</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Reach</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Distribution</td><td align="left" valign="top" rowspan="1" colspan="1">Reach</td><td align="left" valign="top" rowspan="1" colspan="1">Reach<break/>Penetration</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Sustainability</italic>
</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>-</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Affordability</td><td align="left" valign="top" rowspan="1" colspan="1">Sustainment phase<break/>Maintenance<break/>Scale-up</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Outcome</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Proximal outcomes (e.g., opioid use behavior),<break/>Distal outcomes (e.g., opioid overdose mortality)</td><td align="left" valign="top" rowspan="1" colspan="1">Primary outcome<break/>Health utility (e.g., quality-adjusted life year [QALY])<break/>Effectiveness</td><td align="left" valign="top" rowspan="1" colspan="1">Implementation outcomes (e.g., appropriateness, feasibility)<break/>Service outcomes (e.g., effectiveness, equity)<break/>Client outcomes (e.g., satisfaction)<break/>Health outcome (e.g., substance use)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Challenges</italic>
</bold>
<break/>
<bold>
<italic toggle="yes">Barriers</italic>
</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">Confounders</td><td align="left" valign="top" rowspan="1" colspan="1">Confounders</td><td align="left" valign="top" rowspan="1" colspan="1">Implementation determinants<break/>Barriers<break/>Facilitators</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T3"><label>Table 3.</label><caption><p id="P45">Application of Epidemiology, Economic Evaluation, and Implementation Science within the CDC Evaluation Framework</p></caption><table frame="box" rules="all"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="center" valign="top" colspan="1">CDC Evaluation Framework Phase (<xref rid="R12" ref-type="bibr">12</xref>)</th><th colspan="3" align="center" valign="bottom" rowspan="1">Disciplinary Examples and Opportunities for Synergy</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Epidemiology</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Economic Evaluation</italic>
</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Implementation Science</italic>
</th></tr></thead><tbody><tr><td rowspan="2" align="left" valign="top" colspan="1">Assess context</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Assist in the prioritization of programs</italic></bold><break/>Obtain data on substance use outcomes among adolescents in a school district and review available evidence on potential programs to identify which have the most potential to address the problem at hand. Often quantitative data that may come from health service records as well as youth surveys and school-based records.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Assess the cost literature on existing programs</italic></bold><break/>Identify and assess what cost literature exists on existing SBI programs as this may allow for determining what costs do not need to be collected because some are already available and determine what costs may need to be collected during the <italic toggle="yes">Gather Credible Evidence</italic> phase.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Develop partnerships</italic></bold><break/>Partnerships developed during the assessing context phase can help build buy-in among formal and informal partners (e.g., school boards, school leaders and staff, parent groups) to facilitate successful evaluation of the SBI through, for example, participation in qualitative focus groups, interviews, and surveys.</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><bold>Opportunities for Synergy:</bold> Engaging partners in the acquisition of epidemiologic data as well as developing partnerships to better understand what the existing programs are and where to identify cost-related literature for those SBI programs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Describe the program</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Identify risk factors and causes of disease</italic></bold><break/>For a school-based SBI program, this might include identifying past trends and historical information on youth substance use behaviors.</td><td align="left" valign="top" style="border-top: solid 1px" rowspan="1" colspan="1"><bold><italic toggle="yes">Identify activities to cost using the program logic model</italic></bold><break/>In order to carry out activity-based costing, the activities in the SBI program logic model inform which activities are selected to cost. If the SBI program included substance use prevention counseling with students, identifying activities to cost might include consideration of the counselorrelated activities including preparing for the session with students, carrying out the session, and following up with a phone call or emailing students after the session is complete to schedule a follow-up.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Identify implementation outcomes</italic></bold><break/>Identification of implementation outcomes may help to define and describe implementation strategies to integrate the SBI program into the school. If the SBI program included a counseling component, it may be important to assess implementation outcomes like feasibility and acceptability among the school counselors via qualitative interviews or surveys.</td></tr><tr><td align="left" valign="top" style="border-bottom: solid 1px" rowspan="1" colspan="1"/><td colspan="3" align="left" valign="top" rowspan="1"><bold>Opportunities for Synergy:</bold> Epidemiologists, economists, and implementation scientists work with program evaluators to better understand and define the outputs of the SBI program by defining what the intermediate requirements are to achieve the primary health-related outcomes desired. The types of economic analyses planned, such as cost-effectiveness or budget impact analysis, will require using the inputs, activities, and outcomes of the logic model.</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Focus the evaluation questions and design</td><td rowspan="2" align="left" valign="top" colspan="1"><bold><italic toggle="yes">Determine outcome data sources</italic></bold><break/>In design considerations for evaluation of an SBI program, this might include whether to have another school not implementing the SBI as a comparison group.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Develop an economic evaluation plan</italic></bold><break/>Economic evaluation plan within the larger evaluation design for the SBI program, including decisions about approach (e.g., taking a health care sector or school-based health center vs. societal analytic perspective) and plans for collecting and analyzing the cost-related data</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Describe an implementation plan</italic></bold><break/>Through qualitative methods, identifying who will be delivering the SBI program in the school setting and what are the needed implementation strategies.</td></tr><tr><td colspan="2" align="left" valign="top" rowspan="1"><bold>Opportunities for Synergy:</bold> Costing of the implementation strategies in addition to intervention delivery.</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Gather credible evidence</td><td rowspan="2" align="left" valign="top" colspan="1"><bold><italic toggle="yes">Identify intervention impacts Estimate individual risk of disease</italic>.</bold><break/>This includes assessing the impacts of an SBI on the population of focus, such as what changes in substance use behaviors may have occurred among students because of the SBI.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Collect start up and intervention cost data</italic>.</bold><break/>In some instances, qualitative data collection such as conducting interviews among persons delivering the SBI, may help to ensure data collected are accurate and consistent.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Describe and track program adaptations</italic>.</bold><break/>Using qualitative methods, detail and describe each of the SBI intervention components and track any program adaptations that may occur, for example due to the intervention context in order to understand why certain substance use outcomes were or were not achieved.</td></tr><tr><td colspan="2" align="left" valign="top" rowspan="1"><bold>Opportunities for Synergy</bold> The intervention component descriptions can be helpful for providing background and detail on the activities being measured for cost purposes.</td></tr><tr><td rowspan="3" align="left" valign="top" colspan="1">Generate and support conclusions</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Interpret sensitivity analyses in light of primary outcomes</italic></bold><break/>Conclusions about the impact of the SBI on substance use behavior outcomes should be based on the results, including results from any sensitivity analyses such as looking at impacts specific to certain student population or school.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Assess value of intervention and potential budget impacts in wider dissemination</italic>.</bold><break/>This includes carrying out the cost-effectiveness analysis and budget impact analysis for the school-based setting of the SBI program.</td><td rowspan="2" align="left" valign="top" colspan="1"><bold><italic toggle="yes">Interpret outcomes achieved in light of implementation outcomes</italic>.</bold><break/>The findings based on decisions made in the earlier phases of describing the SBI program and focusing the evaluation will be pivotal for the justification of conclusions.</td></tr><tr><td colspan="2" align="left" valign="top" rowspan="1"><bold>Opportunities for Synergy</bold> Strong integration of the epidemiologic and economic methods is needed to appropriately analyze the data, following the specified methodological plan.</td></tr><tr><td colspan="3" align="left" valign="top" rowspan="1"><bold>Opportunities for Synergy</bold> Qualitative implementation outcomes can help triangulate quantitative epidemiological and cost outcomes.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Act on findings</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Share findings linking disease cause, associations, and potential solutions</italic></bold><break/>Epidemiologic methods can identify causes of substance use misuse, along with associations and potential solutions that can help inform policy and public health decisions on substance use prevention programming</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Share cost findings with policymakers</italic></bold><break/>Engagement with influential policymakers in the school and government policy space around financing strategies and opportunities for embedding an effective SBI into school-based setting through consideration of cost-related findings.</td><td align="left" valign="top" rowspan="1" colspan="1"><bold><italic toggle="yes">Disseminate best practices</italic></bold><break/>This is an opportunity to leverage the cross-cutting action of &#x0201c;engage collaboratively&#x0201d; &#x02013; given the number of interested parties for a school-based intervention, an analysis of those parties, their roles, and the preferred communication methods facilitates dissemination.</td></tr></tbody></table></table-wrap><boxed-text id="BX1" position="float"><caption><title>Highlights</title></caption><list list-type="bullet" id="L2"><list-item><p id="P55">The disciplines of epidemiology, economic evaluation, and implementation science have confusing and conflicting terminologies when applied to program evaluation</p></list-item><list-item><p id="P56">Clearer understanding of how these disciplines overlap and where they differ are needed in program evaluation</p></list-item><list-item><p id="P57">Program evaluations and evaluators benefit for clarity on how to integrate epidemiology, economic evaluation, and implementation science methods into evaluations</p></list-item><list-item><p id="P58">Examples of how epidemiology, economic evaluation, and implementation science fit within program evaluation are described in the context of a program evaluation framework</p></list-item></list></boxed-text></floats-group></article>